Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure

ACS Medicinal Chemistry Letters

Volumn 4, Issue 11, 2013, Pages 1074-1078

  Suzuki, Hideyuki ^a   Utsunomiya, Iwao ^a   Shudo, Koichi ^a   Fujimura, Takaji ^b   Tsuji, Masakatsu ^b   Kato, Issei ^b   Aoki, Toshiaki ^b   Ino, Akira ^b   Iwaki, Tsutomu ^b  

^a Kawasaki   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Antibacterial; condensed heteroaromatic ring; methicillin resistant Staphylococcus aureus; oxazolidinone

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIINFECTIVE AGENT; CYTOCHROME P450; OXAZOLIDINONE DERIVATIVE;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SUZUKI REACTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84887900586     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400280z     Document Type: Article

References (25)

1. Ender, M.; McCallum, N.; Adhikari, R.; Berger-Bächi, B. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus Antimicrob. Agents Chemother. 2004, 48, 2295-2297
2. Uttley, A. H. C.; Collins, C. H.; Naidoo, J.; George, R. C. Vancomycin-resistant enterococci Lancet 1988, 1, 57-58
3. Goldstein, F. W. Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non-β-lactam antibiotics J. Antimicrob. Chemother. 1999, 44, 141-144
4. Brickner, S. J. Oxazolidinone antibacterial agents Curr. Pharm. Des. 1996, 2, 175-194
5. Michalska, K.; Karpiuk, I.; Krol, M.; Tyski, S. Recent development of potent analogues of oxazolidinone antibacterial agents Bioorg. Med. Chem. 2013, 21, 577-591
6. Moellering, R. C., Jr. Linezolid: The first oxazolidinone antimicrobial Drugs Drug Ther. 2003, 138, 135-142
7. Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J. Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 2001, 358, 207-208
8. Gonzales, R. D.; Schreckenberger, P. C.; Graham, M. B.; Kelkar, S.; Den-Besten, K.; Quinn, J. P. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid Lancet 2001, 357, 1179
9. Toh, S.; Xiong, L.; Arias, C. A.; Villegas, V.; Lolans, K.; Quinn, J.; Mankin, A. S. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid Mol. Microbiol. 2007, 64, 1506-1514
10. Renslo, A. R. Antibacterial oxazolidinones: emerging structure-toxicity relationships Expert Rev. Anti-Infect. Ther. 2010, 8, 565-574
11. Paget, S. D.; Foleno, B. D.; Boggs, C. M.; Goldschmidt, R. M.; Hlasta, D. J.; Weidner-Wells, M. A.; Werblood, H. M.; Wira, E.; Bush, K.; Macielag, M. J. Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones Bioorg. Med. Chem. Lett. 2003, 13, 4173-4178
12. Das, B.; Rundra, S.; Yadav, A.; Ray, A.; Raja Rao, A. V. S.; Srinivas, A. S. S. V.; Soni, A.; Saini, S.; Shukla, S.; Pandya, M.; Bhateja, P.; Malhotra, S.; Mathur, T.; Arora, S. K.; Rattan, A.; Mehta, A. Synthesis and SAR of novel oxazolidinones: Discovery of ranbezolid Bioorg. Med. Chem. Lett. 2005, 15, 4261-4267
13. Bambeke, F. V.; Reinert, R. R.; Appelbaum, P. C.; Tulkens, P. M.; Peetermans, W. E. Multidrug-resistant Streptococcus pneumoniae infections Drugs 2007, 67, 2355-2382
14. Philippe, P.; Carisa, D. A.; Edward, F.; Purvi, M.; Anita, D. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections. The ESTABLISH-1 randomized trial J. Am. Med. Assoc. 2013, 309, 559-569
15. Suzue, S.; Hirobe, M.; Okamoto, T. Synthetic antimicrobials. II. Synthesis of pyrazolo[1,5-a]pyridine derivatives. (1) Chem. Pharm. Bull. 1973, 21, 2146-2160
16. Villemagne, B.; Crauste, C.; Flipo, M.; Baulard, A. R.; Deprez, B.; Willand, N. Tuberculosis: The drug development pipeline at a glance Eur. J. Med. Chem. 2012, 51, 1-16
17. Hales, N. J.; Weber, T. P.; Gravestock, M. B.; Carcanague, D. R.; Hauck, S. I. Oxazolidinone and/or isoxazoline derivatives as antibacterial agents. PCT Int. Appl. WO200448392, 2004.
18. Kendall, J. D.; Giddens, A. C.; Tsang, K. Y.; Frédérick, R.; Marshall, E. S.; Singh, R.; Lill, C. L.; Lee, W.-J.; Kolekar, S.; Chao, M.; Malik, A.; Yu, S.; Chaussade, C.; Buchanan, C.; Rewcastle, G. W.; Baguley, B. C.; Flanagan, J. U.; Jamieson, S. M. F.; Denny, W. A.; Shepherd, P. R. Novel pyrazolo[1,5- a ]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR Bioorg. Med. Chem. 2012, 20, 58-68
19. Chytil, M.; Engel, S. R.; Fang, Q. K.; Spear, K. L. Histamine H3 inverse agonists and antagonists and methods of use thereof. PCT Int. Appl. WO201131818, 2011.
20. Yamanaka, M.; Miyake, K.; Suda, S.; Ohhara, H.; Ogawa, T. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1 H)-pyridinone derivatives Chem. Pharm. Bull. 1991, 39, 1556-1567
21. Allen, S.; Schlachter, S. T.; Lyssikatos, J. P.; Zhao, Q.; Topalov, G. T.; Robinson, J. E.; Greschuk, J. M.; Marmsaeter, F. P.; Munson, M. C.; Rizzi, J. P.; Kallan, N. C. Imidazo[1,2-A]pyridine compounds as receptor tyrosine kinase inhibitors. PCT Int. Appl. WO2008124323, 2008.
22. Edmondson, S. D.; Mastracchio, A.; Mathvink, R. J.; He, J.; Harper, B.; Park, Y.-J.; Beconi, M.; Salvo, J. D.; Eiermann, G. J.; He, H.; Leiting, B.; Leone, J. F.; Levorse, D. A.; Lyons, K.; Patel, R. A.; Patel, S. B.; Petrov, A.; Scapin, G.; Shang, J.; Roy, R. S.; Smith, A.; Wu, J. K.; Xu, S.; Zhu, B.; Thornberry, N. A.; Weber, A. E. (2 S,3 S)-3-Amino-4-(3,3-difluoropyrrolidin-1- yl)- N, N -dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl) butanamide: A selective α-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes J. Med. Chem. 2006, 49, 3614-3627
23. Baerfacker, L.; Kast, R.; Griebenow, N.; Meier, H.; Kolkhof, P.; Albrecht-Kuepper, B.; Nitsche, A.; Stasch, J.-P.; Schneider, D.; Teusch, N.; Rudolph, J.; Whelan, J.; Bullock, W.; Pleasic-Williams, S. Substituted 5-aminopyrazoles and use thereof. PCT Int. Appl. WO201020363, 2010.
24. Reck, F.; Zhou, F.; Girardot, M.; Kern, G.; Eyermann, C. J.; Hales, N. J.; Ramsay, R. R.; Gravestock, M. B. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A J. Med. Chem. 2005, 48, 499-506
25. Carcanague, D. R.; Gravestock, M. B. 3-[4-(6-{4,5-Dihydroisoxazol-3-yl} pyridin-3-yl)-3-phenyl]-5-(1 H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial sgents. PCT Int. Appl. WO2005116021, 2005.